Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

002821 Asymchem Laboratories(Tianjin)Co.,Ltd.

Closed 04-18 15:00:00

65.50

+3.61

+5.83%

High65.51	Low63.00	Vol7.49M
Open63.00	D1 Closing61.89	Amplitude4.06%
Mkt Cap23.65B	Tradable Cap21.03B	Total Shares361.00M
T/O486.00M	T/O Rate2.33%	Tradable Shares321.00M
P/B1.32	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"Asymchem Laboratories(Tianjin)Co.,Ltd.","latestPrice":65.5,"timestamp":1744959801000,"preClose":61.89,"halted":0,"volume":7492653,"delay":0,"changeRate":0.0583,"floatShares":321000000,"shares":361000000,"eps":-1.0287,"marketStatus":"Closed","change":3.61,"latestTime":"04-18 15:00:00","open":63,"high":65.51,"low":63,"amount":486000000,"amplitude":0.0406,"askPrice":65.51,"askSize":39,"bidPrice":65.5,"bidSize":274,"shortable":0,"etf":0,"ttmEps":-1.0287,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745199000000},"marketStatusCode":5,"adr":0,"adjPreClose":61.89,"symbolType":"stock","openAndCloseTimeList":[[1744939800000,1744947000000],[1744952400000,1744959600000]],"highLimit":68.08,"lowLimit":55.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360595400,"isCdr":false,"pbRate":1.32,"roa":"--","roe":"5.56%","epsLYR":2.69,"committee":0.562654,"marketValue":23619000000,"turnoverRate":0.0233,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-04-22.","hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"ASYMCHEM","latestPrice":43.1,"timestamp":1744877289036,"preClose":42.2,"halted":0,"volume":221300,"delay":0,"premium":"-38.11"},"floatMarketCap":21049000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2525423600","title":"BRIEF-JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES (TIANJIN) INCREASES TO 5.82% ON APRIL 1 - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2525423600","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525423600?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 22:18","pubTimestamp":1744035488,"startTime":"0","endTime":"0","summary":"BRIEF-JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  INCREASES TO 5.82% ON APRIL 1 - HKEXApril 7  - HKEX:JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  INCREASES TO 5.82% ON APRIL 1 FROM 4.72%JPMORGAN CHASE & CO'S SHORT POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  6821.HK INCREASES TO 2.94% ON APRIL 1 FROM 2.30%Further company coverage: 6821.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL041:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0132","06821","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2525091668","title":"JPMorgan Chase & Co's Long Position in H-Shares of Asymchem Laboratories (Tianjin)  Increases to 5.82% on April 1 From 4.72% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2525091668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525091668?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 17:16","pubTimestamp":1744017390,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL041:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1328615791.USD","BK1191","BK0239","06821","002821","BK0132"],"gpt_icon":0},{"id":"2523507148","title":"BRIEF-Asymchem Laboratories Tianjin Posts FY Net Profit Attributable Of RMB949 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2523507148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523507148?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 00:05","pubTimestamp":1743177940,"startTime":"0","endTime":"0","summary":"BRIEF-Asymchem Laboratories Tianjin Posts FY Net Profit Attributable Of RMB949 MlnMarch 28  - Asymchem Laboratories Tianjin Co Ltd 002821.SZ:FY NET PROFIT ATTRIBUTABLE RMB949 MILLIONFY REVENUE FOR YEAR RMB5.80 BILLIONFurther company coverage: 002821.SZ ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB0LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0239","BK0132","LU1328615791.USD"],"gpt_icon":0},{"id":"2522570976","title":"Asymchem Laboratories Tianjin Co Ltd - FY  Revenue for Year RMB5.80 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522570976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522570976?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 21:47","pubTimestamp":1743169662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB0LC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1328615791.USD","BK0132","002821","BK0239"],"gpt_icon":0},{"id":"2514877673","title":"BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 4.44%, Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877673","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514877673?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 19:07","pubTimestamp":1740654449,"startTime":"0","endTime":"0","summary":"BRIEF-Jpmorgan Chase & Co's Long Position In H-Shares Of Asymchem Laboratories  Decreases To 4.44%, Filing ShowsFeb 27  - HKEX:JPMORGAN CHASE & CO'S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  6821.HK DECREASES TO 4.44% ON FEB 21 FROM 5.26%Further company coverage: 6821.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e047f097f5c140fb593219bdbe008468","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","BK1191","002821","BK0132","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2514628873","title":"JPMorgan Chase & Co's Long Position in H-Shares of Asymchem Laboratories (Tianjin)  Decreases to 4.44% on Feb 21 From 5.26% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2514628873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514628873?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 17:23","pubTimestamp":1740648228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e047f097f5c140fb593219bdbe008468","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["002821","BK1191","BK0239","LU1328615791.USD","06821","BK0132"],"gpt_icon":0},{"id":"2512187171","title":"Asymchem Laboratories Buys Back Over 12 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2512187171","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512187171?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 17:46","pubTimestamp":1739958402,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories   has bought back a total of 12,300,701, or 3.6161%, A shares by way of centralized competitive bidding for 999.6 million yuan as of Tuesday, a same-day bourse filing said.The shares were repurchased by the pharmaceutical services provider at between 71.65 yuan and 102 yuan apiece from March 7, 2024, to Feb. 18, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002821","BK0132","06821","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2506556891","title":"Asymchem Laboratories Forecasts Up to 63% Fall in 2024 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2506556891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506556891?lang=en_us&edition=full_marsco","pubTime":"2025-01-28 10:29","pubTimestamp":1738031389,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories   expects an up to 63% fall in 2024 profit amid lower margins and high research and development costs.The pharmaceutical services provider forecasts an attributable net profit of between 850 million yuan and 1.05 billion yuan for 2024, down from 2.27 billion yuan in 2023, according to a Tuesday filing with the Shenzhen bourse.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","06821","LU1328615791.USD","BK0239","002821","BK0132"],"gpt_icon":0},{"id":"2506062463","title":"BRIEF-Asymchem Laboratories Tianjin Sees Net Profit Attributable RMB850 Mln To RMB1,050 Mln For FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2506062463","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506062463?lang=en_us&edition=full_marsco","pubTime":"2025-01-27 23:24","pubTimestamp":1737991456,"startTime":"0","endTime":"0","summary":"BRIEF-Asymchem Laboratories Tianjin Sees Net Profit Attributable RMB850 Mln To RMB1,050 Mln For FYJan 27  - Asymchem Laboratories Tianjin Co Ltd 002821.SZ:ASYMCHEM LABORATORIES TIANJIN SEES NET PROFIT ATTRIBUTABLE RMB850.00 MILLION RMB1,050.00 MILLION FOR FYFurther company coverage: 002821.SZ ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2506737543","title":"Asymchem Laboratories Tianjin Sees Net Profit Attributable RMB850.00 Mln RMB1,050.00 Mln for FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2506737543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506737543?lang=en_us&edition=full_marsco","pubTime":"2025-01-27 19:59","pubTimestamp":1737979198,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","LU1328615791.USD","BK0132","002821"],"gpt_icon":0},{"id":"2479275604","title":"Asymchem Laboratories  Q3 Net Profit Down 59.7% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2479275604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479275604?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 17:07","pubTimestamp":1730192846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nL4N3M5105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["002821","BK0239","BK0132","LU1328615791.USD"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","stockEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":-0.1912},{"period":"3month","weight":-0.1114},{"period":"6month","weight":-0.1379},{"period":"1year","weight":-0.1418},{"period":"ytd","weight":-0.1392}],"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"36059万元","compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0437},{"period":"3month","weight":0.0108},{"period":"6month","weight":0.0047},{"period":"1year","weight":0.0659},{"period":"ytd","weight":-0.0224}],"survey":"　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。","serverTime":1745074697512,"listedPrice":30.53,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Asymchem Laboratories(Tianjin)Co.,Ltd.,002821,Asymchem Laboratories(Tianjin)Co.,Ltd.股票,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎国际,Asymchem Laboratories(Tianjin)Co.,Ltd.行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股票行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股价,Asymchem Laboratories(Tianjin)Co.,Ltd.股市,Asymchem Laboratories(Tianjin)Co.,Ltd.股票价格,Asymchem Laboratories(Tianjin)Co.,Ltd.股票交易,Asymchem Laboratories(Tianjin)Co.,Ltd.股票购买,Asymchem Laboratories(Tianjin)Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction